M62.58
Muscle wasting and atrophy, not elsewhere classified, other site
Clinical Classification Guidelines
Medical Intelligence & Overview
Muscle wasting and atrophy refer to the loss of muscle mass and strength, which can occur in various parts of the body. The ICD-10 code M62.58 specifically denotes muscle wasting and atrophy affecting sites not classified elsewhere. This condition can result from a variety of underlying health issues, leading to diminished physical capacity and potential complications if left unmanaged. Recognizing the causes, symptoms, and available treatments is crucial for managing this condition effectively.
Causes & Symptoms
Clinical Causes: Chronic illnesses such as cancer, heart failure, and chronic obstructive pulmonary disease (COPD) Neurological disorders including multiple sclerosis, amyotrophic lateral sclerosis (ALS), and stroke Prolonged immobility due to injury or hospitalization Malnutrition and inadequate protein intake Endocrine disorders like hyperthyroidism or adrenal insufficiency Certain medications or treatments that induce muscle loss Age-related muscle degeneration, known as sarcopenia
Key Symptoms: Noticeable decrease in muscle size and strength Muscle weakness affecting daily activities Fatigue and reduced endurance Difficulty performing tasks that require muscle effort Changes in muscle tone; muscles may feel soft or flabby Potential muscle pain or discomfort in affected areas
Diagnostic & Treatment
Diagnosis Path: Diagnosing muscle wasting and atrophy involves a comprehensive medical evaluation, including a physical examination to assess muscle strength and size. Healthcare providers may order laboratory tests, such as blood work to identify underlying conditions, and imaging studies like MRI or ultrasound to evaluate muscle tissue. Electromyography (EMG) can be used to examine muscle electrical activity, helping differentiate between muscle and nerve problems. Documenting the pattern and extent of muscle loss assists in pinpointing potential causes and tailoring management strategies.
Treatment Protocols: Management of muscle wasting and atrophy focuses on addressing the underlying cause and supporting muscle health. Treatment options may include: - Nutritional support with adequate protein and caloric intake - Physical therapy and supervised exercise programs designed to rebuild muscle strength - Pharmacological interventions, where appropriate, to treat underlying conditions - Management of chronic illnesses to control disease progression - Use of assistive devices to aid mobility and functionality - Monitoring and regular follow-up to assess progress and adjust treatment plans Early intervention can significantly improve outcomes and help maintain muscle function and overall quality of life.
Clinical Advice & FAQs
Billing Guidance
Is M62.58 a billable ICD-10 code?
Yes, M62.58 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M62.58?
Clinical documentation must specify the nature of Muscle wasting and atrophy, not elsewhere classified, other site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference